Ardena’s New State-of-the-Art Nanomedicine Facility Secures Full GMP Approval for Manufacturing Ardena’s Oss facility secures GMP approval for nanomedicine manufacturing, enhancing capabilities in innovative drug development.

Liposome development and liposome manufacturing services market is anticipated to grow at a CAGR of nearly 10% till 2035, claims Roots Analysis London, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Liposome Development and Liposome Manufacturing Services Market, 2022-2035” report to its list of offerings. ...

Ocular Drug Delivery Market Size to Outstrip $27,016.20Mn by 2028 Growth Projections at 7.4% CAGR During 2021 to 2028 COVID Impact and Global Analysis by TheInsightPartners.com New York, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Ocular Drug Delivery Market: Key InsightsAccording to our new research study on "Ocular Drug Delivery Market to 2028 – Global Analysis and Forecast – by...

Plandaí Biotechnology's Upcoming Clinical Trial Could Strengthen Case for Phytofare in Treatment of Diabetes NEW YORK, NY--(Marketwired - May 18, 2017) - Plandaí Biotechnology (OTCQB: PLPL) announced that it will conduct a human clinical trial to study the effectiveness of using its highly bioavailable...

Plandaí Biotechnology Changing the Future of Green Tea with Technology Used in Origine 8 Capsules NEW YORK, NY--(Marketwired - May 10, 2017) - Plandaí Biotechnology's (OTCQB: PLPL) Origine 8™ capsules could be the future of green tea. Drinking a cup of green tea tastes great, but unless the eight...